MECHANISMS FOR KETOAMIDE ESCAPE IN VAL55 VARIANTS OF THE HCV NS3/4A PROTEASE DOMAIN

被引：0
|
作者：
Welsch, C. [1 ,2 ,3 ]
Schweizer, S. [4 ,5 ]
Shimakami, T. [3 ]
Antes, I. [4 ,5 ]
Zeuzem, S. [1 ]
Lemon, S. [3 ]
机构：
[1] Goethe Univ Frankfurt, Med Klin 1, Frankfurt, Germany
[2] Max Planck Inst Informat, Saarbrucken, Germany
[3] Univ N Carolina, Chapel Hill, NC USA
[4] Tech Univ Munich, Munich, Germany
[5] Kanazawa Univ, Kanazawa, Ishikawa, Japan
来源：
JOURNAL OF HEPATOLOGY | 2012年 / 56卷
关键词：
D O I：
10.1016/S0168-8278(12)61226-4
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1214
引用
收藏
页码：S482 / S482
页数：1
相关论文
共 50 条
  • [1] Ketoamide Resistance and Hepatitis C Virus Fitness in Val55 Variants of the NS3 Serine Protease
    Welsch, Christoph
    Schweizer, Sabine
    Shimakami, Tetsuro
    Domingues, Francisco S.
    Kim, Seungtaek
    Lemon, Stanley M.
    Antes, Iris
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2012, 56 (04) : 1907 - 1915
  • [2] Interactions of ketoamide inhibitors on HCV NS3/4A protease target: molecular docking studies
    Abdul Wadood
    Muhammad Riaz
    Syed Babar Jamal
    Masaud Shah
    Molecular Biology Reports, 2014, 41 : 337 - 345
  • [3] Interactions of ketoamide inhibitors on HCV NS3/4A protease target: molecular docking studies
    Wadood, Abdul
    Riaz, Muhammad
    Jamal, Syed Babar
    Shah, Masaud
    MOLECULAR BIOLOGY REPORTS, 2014, 41 (01) : 337 - 345
  • [4] In search of better inhibitors of the HCV NS3•4A protease domain.
    Perni, RB
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1999, 217 : U1233 - U1234
  • [5] Solid phase parallel synthesis of alpha-ketoamide inhibitors of NS3•4A HCV Protease.
    Court, JJ
    Cottrell, KC
    Harbeson, SL
    Pitlik, J
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2003, 226 : U18 - U18
  • [6] Natural prevalence of HCV minority variants that are highly resistant to NS3/4A protease inhibitors
    Franco, S.
    Bellido, R.
    Aparicio, E.
    Canete, N.
    Garcia-Retortillo, M.
    Sola, R.
    Tural, C.
    Clotet, B.
    Paredes, R.
    Martinez, M. A.
    JOURNAL OF VIRAL HEPATITIS, 2011, 18 (10) : E578 - E582
  • [7] Structural Analysis of Asunaprevir Resistance in HCV NS3/4A Protease
    Soumana, Djade I.
    Ali, Akbar
    Schiffer, Celia A.
    ACS CHEMICAL BIOLOGY, 2014, 9 (11) : 2485 - 2490
  • [8] Treatment of HCV infection with the novel NS3/4A protease inhibitors
    De Luca, Andrea
    Bianco, Claudia
    Rossetti, Barbara
    CURRENT OPINION IN PHARMACOLOGY, 2014, 18 : 9 - 17
  • [9] Induction of human telomerase by HCV NS3/4A protease-helicase
    Zhu, Zhaowen
    Mathahs, M. Meleah
    Schmidt, Warren N.
    HEPATOLOGY, 2013, 58 : 1171A - 1171A
  • [10] Novel HCV NS3/4A protease inhibitors with tetrazoyl P* groups
    Wang, Guoqiang
    Sun, Ying
    Jiang, Lijuan
    Lu, Xiang
    The-Uyen Phan
    Chen, Zhigang
    McDaniel, Keith K.
    Kempf, Dale J.
    Or, Yat Sun
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2012, 243
12345